vTv Therapeutics Inc (VTVT): Rega marang dodolan

Logo korporat perusahaan vTv Therapeutics Inc. (VTVT)

vTv Therapeutics Inc. (VTVT) focuses on bringing TTP399 to market for the treatment of diabetes and psoriasis. The molecule development process is accelerated by AI and synthesis automation. The company's P/S ratio dynamics reflect the current market valuation, where 1.90 captures the value of this parameter. Growth prospects depend on the successful completion of final clinical trials with the support of external investors.

vTv Therapeutics Inc - Multiplikator P/S VTVT (periode 04.07.2022 - 17.11.2026)

Rincian metrik lan analitis perusahaan vTv Therapeutics, Inc. (VTVT)

- rega saiki lan proyeksi nilai saham:
Ringkesan analitik perusahaan:vtvtherapeutics.com VTVT
Barang utama vTv Therapeutics

The high pricing power potential of vTv Therapeutics Inc. (VTVT) within the inelastic demand segment of diabetic patients drives the asset's investment attractiveness. The price-to-sales ratio dynamics visualize the market valuation of every dollar of sales through the relationship between market capitalization and revenue. This metric allows for the determination of the premium paid for future revenues from the sale of the unique drug Govorestat. Trend analysis helps balance the risk of an overbought asset against the probability of missed opportunity.

Karo sapa vTv Therapeutics Inc. saingan

Rasio rega marang pendapatan ASND (Ascendis Pharma AS)|Rasio rega marang pendapatan madrigalpharma.com MDGL|Corcept Therapeutics Corp (CORT) - Rega marang dodolan|RYTM - Rasio rega marang pendapatan|AKRO: Rasio rega marang pendapatan|MTSR: Multiplikator P/S|MLTX - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Crinetics Corp|NewAmsterdam Pharma Corp (NAMS) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan soleno.life (SLNO)|Kapitalisasi marang pendapatan Amicus Therapeutics FOLD|Rasio kapitalisasi pasar marang pendapatan 89bio Inc|Multiplikator P/S Agios Pharmaceuticals, Inc. AGIO|GPCR: Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan MiMedx Corp MDXG|RZLT (Rezolute Corp) - Kapitalisasi marang pendapatan|Rasio kapitalisasi marang pendapatan LXRX|MBX (MBX Biosciences) - Multiplikator P/S|Kapitalisasi marang pendapatan Altimmune Inc (ALT)|Kapitalisasi marang pendapatan AARD (Aardvark Therapeutics Corp)|Kapitalisasi marang pendapatan Sagimet SGMT|Multiplikator P/S BIOA (BioAge Labs)|Multiplikator P/S Biomea Fusion BMEA|QNCX: Kapitalisasi marang pendapatan|GUTS: Rasio rega marang pendapatan|ATPC (agapeatpgroup.com) - Kapitalisasi marang pendapatan|Rasio kapitalisasi marang pendapatan PLUR|Kapitalisasi marang pendapatan SYBX|LPCN: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S MTNB|SPRB - Rega marang dodolan|Multiplikator P/S GLTO (Galecto Corporation)|Rasio kapitalisasi pasar marang pendapatan CTCX|Lumos Therapeutics - Multiplikator P/S|ONVO: Rasio rega marang pendapatan|Radius Recycling (RDUS) - Rasio rega marang pendapatan